88 related articles for article (PubMed ID: 2694107)
1. [Conjunctivitis of bacterial origin in children. Local antibiotic treatment with tobramycin collyrium].
Fioretti GM; Campanari C
Pediatr Med Chir; 1989; 11(4):421-3. PubMed ID: 2694107
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis].
Robert PY; Bourcier T; Meddeb-Ouertani A; Khairallah M; Zaghloul K; Amraoui A; Bhagat Y; Pop M; Cochereau I
J Fr Ophtalmol; 2010 Apr; 33(4):241-8. PubMed ID: 20223555
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.
Bremond-Gignac D; Mariani-Kurkdjian P; Beresniak A; El Fekih L; Bhagat Y; Pouliquen P; Delval L; Goldschmidt P; Bingen E; Cochereau I
Pediatr Infect Dis J; 2010 Mar; 29(3):222-6. PubMed ID: 19935122
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of effectiveness and tolerance of treatment with azithromycin 1.5% eye drops in bacterial conjunctivitis].
Ambroziak AM; Szaflik JP; Hapunik A
Klin Oczna; 2009; 111(1-3):46-9. PubMed ID: 19517846
[TBL] [Abstract][Full Text] [Related]
5. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.
Protzko E; Bowman L; Abelson M; Shapiro A;
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3425-9. PubMed ID: 17652708
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
Jackson WB; Low DE; Dattani D; Whitsitt PF; Leeder RG; MacDougall R
Can J Ophthalmol; 2002 Jun; 37(4):228-37; discussion 237. PubMed ID: 12095096
[TBL] [Abstract][Full Text] [Related]
7. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
Gallenga PE; Lobefalo L; Colangelo L; Della Loggia G; Orzalesi N; Velati P; Bujtar E; Ponte F; Damiani S; Bucci MG; Bonini S; Curatola MR; Palma LA; Bonomi L; Tomazzoli Gerosa L; Pagliarusco A; Milan E; Jauch A
Ophthalmologica; 1999; 213(4):250-7. PubMed ID: 10420109
[TBL] [Abstract][Full Text] [Related]
8. Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis.
Denis F; Chaumeil C; Goldschmidt P; Delval L; Pouliquen P; Cochereau I; Chainier D; De Barbeyrac B
Eur J Ophthalmol; 2008; 18(6):858-68. PubMed ID: 18988154
[TBL] [Abstract][Full Text] [Related]
9. 3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.
Cochereau I; Meddeb-Ouertani A; Khairallah M; Amraoui A; Zaghloul K; Pop M; Delval L; Pouliquen P; Tandon R; Garg P; Goldschmidt P; Bourcier T
Br J Ophthalmol; 2007 Apr; 91(4):465-9. PubMed ID: 17050578
[TBL] [Abstract][Full Text] [Related]
10. Bacterial conjunctivitis in children: antibiotic eye drops only if eye washing is ineffective.
Prescrire Int; 2007 Jun; 16(89):120-1. PubMed ID: 17585426
[TBL] [Abstract][Full Text] [Related]
11. Topical netilmicin compared with tobramycin in the treatment of external ocular infection.
Milazzo G; Papa V; Carstocea B; Chercota G; Rodica P; Gafencu O; Santocono M
Int J Clin Pharmacol Ther; 1999 May; 37(5):243-8. PubMed ID: 10363623
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.
Bremond-Gignac D; Nezzar H; Bianchi PE; Messaoud R; Lazreg S; Voinea L; Speeg-Schatz C; Hartani D; Kaercher T; Kocyla-Karczmarewicz B; Murta J; Delval L; Renault D; Chiambaretta F;
Br J Ophthalmol; 2014 Jun; 98(6):739-45. PubMed ID: 24526744
[TBL] [Abstract][Full Text] [Related]
13. A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.
Kernt K; Martinez MA; Bertin D; Stroman D; Cupp G; Martínez C; Tirado M; Guasch J;
Eur J Ophthalmol; 2005; 15(5):541-9. PubMed ID: 16167284
[TBL] [Abstract][Full Text] [Related]
14. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
[TBL] [Abstract][Full Text] [Related]
15. Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis.
Silver LH; Woodside AM; Montgomery DB
Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S55-63. PubMed ID: 16257311
[TBL] [Abstract][Full Text] [Related]
16. Use of Brulamycin (tobramycin) eye drops in the preoperative and postoperative treatment of ophthalmotomies.
Kovács B; Krassói E
Ther Hung; 1994; 42(1):48-51. PubMed ID: 7761965
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.
Jacobson JA; Call NB; Kasworm EM; Dirks MS; Turner RB
Antimicrob Agents Chemother; 1988 Dec; 32(12):1820-4. PubMed ID: 3072923
[TBL] [Abstract][Full Text] [Related]
18. [A multicenter randomized study of fusidic acid ophthalmic gel and rifamycine eyedrops in acute conjunctivitis].
Adenis JP; Arrata M; Gastaud P; Limon S; Massin M
J Fr Ophtalmol; 1989; 12(4):317-22. PubMed ID: 2697725
[TBL] [Abstract][Full Text] [Related]
19. Primary meningococcal conjunctivitis in children.
Neoh C; Agius-Fernandez A; Kaye SB; Molyneux EM; Hart CA
Br J Clin Pract; 1994; 48(1):27-8. PubMed ID: 8179978
[TBL] [Abstract][Full Text] [Related]
20. [Bacterial conjunctivitis--diagnosis and therapy update].
Messmer EM
Klin Monbl Augenheilkd; 2012 May; 229(5):529-33. PubMed ID: 22592344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
